Background: Homocystinuria due to cystathionine beta synthase (CBS) deficiency presents with a wide clinical spectrum. Treatment by the enteral route aims at reducing homocysteine levels by using vitamin B6, possibly methionine-restricted diet, betaine and/or folate and vitamin B supplementation. Currently no nutritional guidelines exist regarding parenteral nutrition (PN) under acute conditions.
Methods: Exhaustive literature search was performed, in order to identify the relevant studies describing the pathogenesis and nutritional intervention of adult classical homocystinuria requiring PN. Description of an illustrative case of an adult female with CBS deficiency and intestinal perforation, who required total PN due to contraindication to enteral nutrition.
Results: Nutritional management of decompensated classical homocystinuria is complex and currently no recommendation exists regarding PN composition. Amino acid profile and monitoring of total homocysteine concentration are the main tools enabling a precise assessment of the severity of metabolic alterations. In case of contraindication to enteral nutrition, compounded PN will be required, as described in this paper, to ensure adequate low amounts of methionine and others essential amino acids and avoid potentially fatal toxic hypermethioninemia.
Conclusions: By reviewing the literature and reporting successful nutritional management of a decompensated CBS deficiency using tailored PN with limited methionine intake and n-3 PUFA addition, we would like to underscore the fact that standard PN solutions are not adapted for CBS deficient critical ill patients: new solutions are required. High methionine levels (>800 μmol/L) being potentially neurotoxic, there is an urgent need to improve our knowledge of acute nutritional therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clnu.2017.07.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical, biochemical and molecular characteristics of classic homocystinuria in Saudi Arabia and the impact of newborn screening on prevention of the complications: A tertiary center experience.
JIMD Rep
January 2025
Department of Pediatrics Prince Sultan Military Medical City (PSMMC) Riyadh Saudi Arabia.
Background: Classic homocystinuria (HCU) is a rare inborn metabolic disease that is generally asymptomatic at birth. If untreated, it can cause a wide range of complications including intellectual disability, lens dislocation, and thromboembolism. This study aimed to describe the natural history and the molecular findings of patients with HCU, and to assess the importance of early diagnosis.
View Article and Find Full Text PDFImpact of primary sequence changes on the self-association properties of mammalian cystathionine beta-synthase enzymes.
Protein Sci
December 2024
Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Cystathionine beta-synthase (CBS) is an evolutionarily conserved enzyme that plays a key role in mammalian sulfur amino acid biochemistry, mutations in which are the cause of classical homocystinuria (HCU), an inborn error of metabolism. Although there is agreement in the literature that CBS is a homomultimer, its precise structure is a source of confusion. Here, we performed a series of experiments examining the quaternary structure of various wild-type and mutant CBS enzymes using a combination of native gel electrophoresis, in situ activity assays, analytical ultracentrifugation, and gel filtration.
View Article and Find Full Text PDFMechanism of action and impact of thiol homeostasis on efficacy of an enzyme replacement therapy for classical homocystinuria.
Redox Biol
November 2024
Department of Pharmacology, University of Fribourg, Faculty of Science and Medicine, Fribourg, Switzerland. Electronic address:
Article Synopsis
- Homocystinuria (HCU) is caused by a deficiency in the enzyme cystathionine beta-synthase (CBS), leading to high levels of homocysteine in the body; it can be managed through a special diet and vitamin B supplementation, but there is currently no cure.
- Recent research shows that enzyme replacement therapy (ERT) using human CBS can significantly lower homocysteine levels in mice, though it doesn't fully normalize them, prompting further investigation into how ERT works.
- The study found that reducing homocysteine levels enhances CBS function, and using biological reductants like N-acetylcysteine can improve the effectiveness of CBS-based ERT, offering new ways to tackle H
Real-time detection of enzymatically formed hydrogen sulfide by pathogenic variants of cystathionine beta-synthase using hemoglobin I of Lucina pectinata as a biosensor.
Free Radic Biol Med
October 2024
Laboratory of Clinical Biochemistry and Metabolism, Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Medical Center, University of Freiburg, 79106, Freiburg, Germany; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany. Electronic address:
Article Synopsis
- Classical homocystinuria results from mutations in the cystathionine β-synthase (CBS) gene, leading to elevated homocysteine levels and various clinical impairments including neurological and vascular issues.
- A new method using hemoglobin from the clam Lucina pectinata allows for real-time quantification of hydrogen sulfide (HS) production by both normal and mutated CBS enzymes.
- The findings demonstrate that wild-type CBS produces more HS than pathogenic variants, providing insights into how CBS structure affects HS production and potentially impacts patient outcomes.
Dysregulation of hepatic one-carbon metabolism in classical homocystinuria: Implications of redox-sensitive DHFR repression and tetrahydrofolate depletion for pathogenesis and treatment.
FASEB J
July 2024
Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Article Synopsis
- Cystathionine beta-synthase-deficient homocystinuria (HCU) is a serious disorder affecting sulfur metabolism, where treatment with betaine is less effective in mice showing low levels of tetrahydrofolate (THF).
- Mice models of HCU displayed a significant accumulation of certain metabolites and a repressed expression of the enzyme dihydrofolate reductase (DHFR), which is necessary for THF generation and metabolic processes.
- The dysfunction in one-carbon metabolism in HCU not only reduces the effectiveness of betaine treatment but also contributes to complications such as decreased nitric oxide (NO) levels, indicating broader implications for disease pathogenesis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!